ivst_admin – Page 2 – NovAccess Global

NovAccess Global Announces Filing of Orphan Drug Application for TLR-AD1

Orphan Drug Application Filing

NovAccess Global CEO Dwain Irvin Featured on MoneyTV

NovAccess Global to Participate in LD Micro Invitational XII Conference

NovAccess Global Closes its Redemption Transaction and expands the Executive Board

NovAccess Global, Inc.’s CEO to attend BIO Conference in New York

NovAccess Global, Inc. Names Neil Laird, Chief Financial Officer

Neil Laird

NovAccess Global, Inc. Expands Advisory Board

NovAccess Global, Inc. to Present at the Prestigious Society for Brain Mapping and Therapeutics 2021 World Congress

NovAccess Global, Inc. Announces Successful Completion of Pre-IND Meeting with FDA

NovAccess Global Readies for Development of Novel Immunotherapies for Brain Tumor Patients with pre-IND meeting scheduled with the FDA and Files Form 10-K for Fiscal 2020 and Form 10-Q for FQ1/FQ2, 2021

Revolutionary advances in the understanding of how our bodies can fight cancer, and how to put that information to use in treating existing tumors. NovAccess Global’s team of experts is working to strengthen the capability of the human body’s defense against cancer.

Forward-Looking Statements

Contact Us

JOIN US

Stay up-to-date with our journey

Privacy Policy

Forward-Looking Statements